Stage 2 Mesothelioma
Like some other early-stage cancers, stage 2 mesothelioma has only spread to nearby organs and tissue. Median survival is 19 – 67 months, depending on mesothelioma type. Many life-extending treatment options may be available for stage 2 patients. These factors may lead to a favorable prognosis.
Learn More About Stage 2 Mesothelioma in Our Free Guide Free 2026 Mesothelioma Guide
What Is Stage 2 Mesothelioma Cancer?
In stage 2 mesothelioma, the cancer has typically spread to nearby organs and tissues. Depending on the patient’s type of mesothelioma, different areas of the body may be affected. At this early stage, spreading is localized, and patients may experience few and mild symptoms. Stage 2 median overall survival is 19 – 67 months.
- Localized spread: Stage 2 mesothelioma has spread beyond the original tumor site to nearby tissues, organs and possibly lymph nodes, but it has not spread to distant parts of the body.
- More noticeable symptoms: Compared to stage 1, symptoms such as chest pain, shortness of breath or abdominal pain and bloating may become more noticeable as stage 2 mesothelioma progresses.
- Treatable: Many patients with stage 2 mesothelioma remain eligible for surgery, often combined with chemotherapy, immunotherapy or radiation therapy as part of a multimodal treatment plan.
- Prognosis: Patients diagnosed with stage 2 mesothelioma generally have a better prognosis than those diagnosed with stages 3 or 4, especially when evaluated and treated by an experienced mesothelioma specialist.
- Specialty care: Patients with stage 2 mesothelioma who seek care at specialized mesothelioma cancer centers may have access to experienced doctors, personalized treatment plans and clinical trials.
In early-stage diagnoses, like stage 2, patients typically have many mesothelioma treatment options, including aggressive therapeutic surgeries. Early diagnoses and treatments can result in more favorable prognoses. A more favorable prognosis may mean longer patient life expectancies.
Pleural mesothelioma is the only form with its own widely accepted staging system. Other forms of mesothelioma may be staged using more general cancer staging systems.
Mesothelioma is categorized into four stages. Early stages include stage 1 and stage 2. Stage 3 and stage 4 are considered later stages.
What Are the Symptoms of Stage 2 Mesothelioma Cancer?
Stage 2 mesothelioma symptoms often start mild. As the disease progresses, mesothelioma symptoms may worsen or become more prominent. Symptoms vary depending on where in the body the cancer has formed.
Because of the mild and varied nature of symptoms, early-stage mesothelioma may be misdiagnosed as more common conditions. For example, pleural mesothelioma may be misdiagnosed as other lung conditions, such as lung cancer.
- Abdominal pain
- Chest pain
- Chronic coughing
- Fever
- Fluid buildup (peritoneal or pleural effusion)
- Shortness of breath (dyspnea)
- Unexplained weight loss
*List is a combination of common pleural, peritoneal, pericardial and testicular symptoms
Patients with a known history of asbestos exposure should be especially sensitive to any changes in their bodies. If patients have symptoms they believe could be caused by mesothelioma, they should contact a physician right away. Investigating early symptoms, even minor ones, may lead to early detection and improved prognosis.
Did You Know?
Research indicates mesothelioma patients who undergo some form of treatment may live at least twice as long as those who do not receive treatment.
Studies suggest life expectancy for mesothelioma patients who do not receive treatment is about six months. Patients who undergo some form of treatment may survive one year or longer.
Stage 2 Mesothelioma Cancer Diagnosis and Causes
Mesothelioma can be difficult to diagnose, in part because of the long period between asbestos exposure and symptom onset. The only definitive way to diagnose mesothelioma is by testing a biopsy tissue sample. However, doctors will often perform other tests before a biopsy to rule out other diseases.
A 2026 review published in Cancers explored the diagnostic challenges of pleural mesothelioma. Diagnosing stage 2 pleural mesothelioma can be difficult because its symptoms are similar to those of more common lung and heart conditions. The review also found that the disease is rare and that no single test can confirm the diagnosis. Instead, doctors rely on a combination of imaging tests, a tissue biopsy and the expertise of a multidisciplinary team to make an accurate diagnosis.
The diagnostic process often begins with an overview of the patient’s medical history. Patients with known asbestos contact should be sure to mention their exposure at this time. After that, doctors may conduct a physical exam to look for lumps, body changes and abnormalities. Then, doctors may order imaging scans and blood tests.
If these general tests do not rule out cancer, doctors may order a biopsy. A biopsy procedure removes fluid or tissue from the patient for testing. This testing can determine mesothelioma’s presence.
All stages of mesothelioma can be difficult to diagnose. Early stages, like stage 2, may present even more of a challenge because the cancer is less developed and may not cause symptoms. Other reasons for diagnosis difficulty include:
- Latency period: Mesothelioma can take 50 years or more to develop after asbestos exposure. This long latency period may cause people to forget their history of asbestos exposure. Without evidence of exposure, doctors may not immediately suspect mesothelioma, which can delay diagnosis.
- Rarity: About 3,000 mesothelioma cases are diagnosed annually in the U.S. This rarity means some doctors may not recognize the disease at first or be equipped to diagnose it. For this reason, patients should seek a mesothelioma specialist for care.
- Symptom presentation: Initial symptoms may be vague, mild or easily confused for other conditions.
Patients with known asbestos exposure can reduce the chance of misdiagnosis by mentioning their history to their doctor.
Asbestos Exposure and Mesothelioma
Asbestos exposure is the only known cause of mesothelioma. Individuals may be exposed at work, home or going about their daily lives. Occupational exposure is common in certain industries, such as construction, manufacturing and shipbuilding.
Individuals who develop mesothelioma may be eligible to receive compensation. Many mesothelioma patients were exposed through the fault of negligent companies. Mesothelioma lawyers can help patients receive the compensation they deserve for their illnesses. Contact an experienced mesothelioma attorney today to learn more about compensation options.
Request a Free 2026 Mesothelioma Guide Our packet will be sent to you within 24 hours Request Free Guide
Stage 2 Mesothelioma Cancer by Type
Each mesothelioma type has different stage 2 characteristics, associated prognoses and effective treatments.
Stage 2 Pleural Mesothelioma
Malignant pleural mesothelioma is the most common type of the cancer. It develops in the lining around the lungs, called the pleura. Because of its prevalence, there are three staging systems doctors may use to determine disease progression. These include:
- The TNM system
- The Brigham staging system
- The Butchart system
Physicians most commonly use the TNM system to stage pleural mesothelioma. This system considers the size and extent of the tumor, the number of affected lymph nodes and metastasis (spreading).
Stage 2 Pleural Mesothelioma Characteristics
Stage 2 pleural mesothelioma has its own characteristics:
- Mesothelioma tumors develop in the pleura (lung lining) but only on one side of the body.
- Cancer cells may have spread into the adjacent lung, diaphragm and nearby lymph nodes.
- There is no distant metastasis.
Stage 2 Peritoneal Mesothelioma
Peritoneal mesothelioma is the second most common form of the disease. It develops in the lining around the abdomen, called the peritoneum. Doctors do not have a staging system specific to peritoneal mesothelioma.
Mesothelioma doctors may use the Peritoneal Cancer Index (PCI) to estimate stage. This system is used to help stage a variety of abdominal cancers but is not a mesothelioma-specific staging system. Using the PCI, doctors score regions of the abdomen based on the number and size of tumors. The total score indicates the stage.
Stage 2 Peritoneal Mesothelioma Characteristics
Stage 2 peritoneal mesothelioma is characterized by little spread and a lower-end PCI score.
- Stage 2 peritoneal cancer has a PCI score of 11 – 20.
- The cancer may have spread to nearby organs, tissues or lymph nodes.
- There is no involvement of distant organs.
Of the four main types of mesothelioma, peritoneal patients typically experience a more favorable prognosis. Early-stage diagnosis improves prognosis even further.
Stage 2 Pericardial Mesothelioma
Pericardial mesothelioma accounts for less than 1% of all mesothelioma diagnoses. This rare form develops in the lining around the heart, called the pericardium. Because it is rare, pericardial mesothelioma does not have its own staging system. Research into different characteristics of pericardial mesothelioma stages is limited. Doctors may not even stage this type.
Pericardial mesothelioma patients may still be eligible for certain treatments. Surgeries, multimodal treatments and palliative care may help improve pericardial mesothelioma prognosis.
Stage 2 Testicular Mesothelioma
Testicular mesothelioma develops in the tunica vaginalis, the lining around the testicle. Less than 1% of all mesothelioma cases develop in the tunica vaginalis. Information about staging of testicular mesothelioma is limited. However, doctors may be able to treat this rare disease to extend survival and improve quality of life.
Stage 2 Mesothelioma Cancer Treatments
Stage 2 mesothelioma treatment plans typically take a multimodal approach. Multimodal mesothelioma treatment commonly combines surgery, chemotherapy, immunotherapy or radiation. Multimodal treatments differ by individual case and type of mesothelioma.
Mesothelioma doctors will consider the unique details of a patient’s case when putting together their treatment plan. Patients should seek care from a doctor with extensive mesothelioma experience to ensure they are receiving the most effective treatment options available.
The most important piece of advice I can give someone is find a specialist. Finding a specialist is paramount because they know the ins and outs of this disease and how to treat it better than anybody else. That’s what I attribute to my long survival.
Heather Von St. James
In stage 2 patients, physicians can often recommend aggressive therapies. These treatment plans attempt to remove as much of the cancer as possible. Treatment costs for stage 2 mesothelioma vary depending on a patient’s treatment plan, healthcare providers and insurance. However, financial assistance is available to help patients and loved ones cover mesothelioma medical expenses.
Palliative treatments may also accompany standard therapies. In some cases, palliative care may reduce mesothelioma symptoms for stage 2 patients. Palliative care may also treat symptoms resulting from traditional treatment methods, such as chemotherapy.
- Mesothelioma type (pleural or peritoneal)
- Cell type (epithelioid, sarcomatoid or biphasic)
- How far the cancer has spread
- Whether surgery is possible
- Patient’s age and overall health
- Personal treatment goals and preferences
- Surgery
- Chemotherapy
- Immunotherapy
- Radiation therapy
- Multimodal therapy
- Clinical trials
Surgery
For stage 2 patients, surgery attempts to remove as many mesothelioma tumors as possible. Patients diagnosed at this stage may undergo different surgeries for different types of mesothelioma.
Stage 2 pleural mesothelioma patients may receive extrapleural pneumonectomy (EPP) or pleurectomy with decortication (P/D). Stage 2 peritoneal mesothelioma patients may receive cytoreductive surgery (CRS) or a peritonectomy.
- EPP removes the affected lung and surrounding tissues.
- P/D removes the lung lining and cancerous tissue. It does not remove the affected lung.
- CRS surgeries remove as much of the tumor as possible. Patients may hear CRS referred to as debulking or peritonectomy.
Chemotherapy
For stage 2 patients, chemotherapy can be administered before a main treatment type or after the main therapy. This helps to kill cancer cells.
In the early stages of mesothelioma, peritoneal patients may be eligible for surgery combined with heated intraperitoneal chemotherapy wash (HIPEC). This treatment has improved longer-term survival rates. In one study, stage 2 peritoneal mesothelioma patients treated with CRS and HIPEC experienced a 5-year survival rate of 62%. Some of these patients also received additional chemotherapy after CRS and HIPEC.
Immunotherapy
Immunotherapy uses a patient’s immune system to fight cancer. It has already helped extend survival for some mesothelioma patients. Different types of immunotherapy operate in different ways. Immunotherapy can be used as part of a multimodal treatment.
In one study, pleural mesothelioma patients of all stages received the immunotherapy treatment duo Opdivo® and Yervoy®. The study compared this treatment to a chemotherapy regimen. Patients treated with Opdivo+Yervoy lived longer than those who received chemotherapy treatment.
The drug duo of Opdivo+Yervoy is a recommended treatment for some mesothelioma cases. Stage 1 and stage 2 patients may benefit from immunotherapy over chemotherapy.
Radiation Therapy
Radiation may be administered before or after surgery. This therapy helps decrease the spread or recurrence of mesothelioma cells following surgical procedures. It may be better suited to certain types of mesothelioma.
Studies have shown adjuvant radiation therapy may improve survival for patients with stage 1 and stage 2 pleural mesothelioma. One study from The University of Texas MD Anderson Cancer Center found more than 50% of stage 1 and 2 patients treated with adjuvant radiation lived at least two years.
Clinical Trials
Stage 2 patients may be eligible for emerging treatments through clinical trials. Some patients have benefitted from emerging treatments, such as photodynamic therapy and immunotherapy.
Stage 2 Mesothelioma Cancer Prognosis
Stage 2 mesothelioma patients have a general life expectancy of 19 – 67 months. Patients diagnosed in stage 2 typically have a more favorable mesothelioma prognosis than those diagnosed later. In the early stages, the disease is still localized and can often be addressed with a range of treatment options and combinations.
Prognosis can be affected by a variety of factors. These factors may impact life expectancy, treatment options and more.
- Tumor location: Certain types of mesothelioma may have better prognoses than others. For instance, an early-stage pleural mesothelioma prognosis is generally favorable when compared to other types.
- Cell type: Some mesothelioma cell types respond better to treatments than others. As a result, these patients may experience a more favorable prognosis.
- Patient age: Younger stage 2 mesothelioma patients often have a more favorable prognosis than older patients.
- Overall health: Patients with good overall health and no pre-existing conditions typically have a more favorable prognosis than those in poor health. They may also be eligible for a wider range of treatment options.
Stage 2 Mesothelioma Life Expectancy
Stage 2 life expectancy with treatment ranges from 19 to 67 months, depending on the type of mesothelioma. Mesothelioma life expectancy is the estimate of how long patients will live with or without treatment. Many patients experience longer life expectancies with treatment.
Treatment options for stage 2 mesothelioma patients include aggressive surgeries and multimodal treatment combinations. These treatments aim to extend life expectancies and improve quality of life. Patients should speak with their care teams about their specific cases. Even patients diagnosed in later stages have gone on to outlive their initial prognoses by several years.
Stage 2 Mesothelioma Survival Rate
The stage 2 mesothelioma 1-year survival rate is 70% for pleural mesothelioma and 86% for peritoneal mesothelioma. Survival rate is the percentage of patients who survive for a given period of time following diagnosis. Survival rates are generally better with treatment than without.
In one study, pleural mesothelioma patients underwent chemotherapy and then pleurectomy/decortication (P/D) surgery. Early-stage patients made up 71% of the study, which includes stage 1 and stage 2 patients. Some patients received extrapleural pneumonectomy (EPP) or follow-up chemotherapy, if necessary. Overall 1-year survival was 93% and 3-year survival was 65%.
Mesothelioma statistics, such as survival rate, come from studies. This data can provide doctors and patients with a better understanding of the disease. However, each diagnosis is unique. Patients should discuss their prognoses with their doctors.
Mesothelioma survival rates are typically provided at the 1-, 2- and 3-year marks. With improvements in research and treatment, 5-year mesothelioma statistics are becoming more common.
These statistics give patients a good estimate of prognosis.
Stage 2 Pleural Mesothelioma Survival Statistics
Researchers have reported the following survival rates for stage 2 patients who underwent treatment:
- 2-year: 39%
- 5-year: 9%
- Median survival: 19 months (compared to 16 months for stage 3)
Stage 2 Peritoneal Mesothelioma Survival Statistics
Peritoneal mesothelioma patients often have the best survival statistics. Researchers have reported the following statistics for stage 2 patients who underwent treatment:
- 3-year: 65%
- 5-year: 52%
- Median survival: 67 months (compared to 56 months for stage 3)
Can Stage 2 Mesothelioma Be Cured?
No stage of mesothelioma is considered curable. However, early-stage diagnosis offers the most favorable prognosis. If diagnosed in stage 1 or 2, patients may be healthier and better able to withstand aggressive treatments. Through treatment, patients may extend their life expectancy by months, years or even more than a decade. Mesothelioma researchers continue to test treatments for early- and late-stage mesothelioma patients.
Long-Term Survivorship After Stage 2 Mesothelioma Diagnosis
Long-term survivorship with mesothelioma is possible. Individuals diagnosed early have the best chance of extended survival. Newer treatments like immunotherapy show promise for longer-term mesothelioma survival. Mesothelioma researchers continue to test this and other treatments to improve outcomes.
Heather Von St. James was diagnosed with mesothelioma in 2005. According to Dana-Farber Cancer Institute, she had stage 2 epithelioid pleural mesothelioma. Without treatment, Heather was given a 15-month life expectancy.
She underwent several rounds of treatment, receiving surgery, chemotherapy and radiation. Heather is now a mesothelioma survivor of more than 20 years.
Common Questions About Stage 2 Mesothelioma Cancer
Is stage 2 mesothelioma difficult to diagnose?
Should you get a second opinion after a stage 2 mesothelioma diagnosis?
How long can you live with stage 2 mesothelioma?
Sources
National Library of Medicine - Diagnostic Challenges in Pleural Mesothelioma; 4/25/2026
American Cancer Society - Survival Rates for Mesothelioma; 2/3/2026
National Library of Medicine - A Diagnostic Approach to Malignant Pleural Mesothelioma; 9/1/2025
Journal of Clinical Oncology - Treatment of Pleural Mesothelioma: ASCO Guideline Update; 1/8/2025
National Cancer Institute - Cancer Staging; 11/14/2022
Financial Assistance for Mesothelioma Patients
Dr. Francis Perry Wilson is the Director of the Clinical and Translational Research Accelerator at the Yale University School of Medicine. He specializes in nephrology and clinical research.
Medically
Reviewed by
James Stevenson, MD
Thoracic Medical Oncologist
Dr. James Stevenson is a Board-Certified Medical Oncologist. He specializes in treating mesothelioma and lung cancer and practices at the Cleveland Clinic in Cleveland, Ohio.
